4//SEC Filing
Sherman Matthew L 4
Accession 0001209191-23-010506
CIK 0001654151other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:07 PM ET
Size
9.1 KB
Accession
0001209191-23-010506
Insider Transaction Report
Form 4
Sherman Matthew L
EVP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-15+65,900→ 65,900 totalExercise: $15.48Exp: 2033-02-14→ Common Stock (65,900 underlying) - Award
Common Stock
2023-02-15+16,488→ 89,116 total - Sale
Common Stock
2023-02-16$15.10/sh−971$14,661→ 88,145 total
Footnotes (3)
- [F1]The reporting person was awarded 16,488 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in three equal installments on each of February 15, 2024, February 15, 2025 and February 15, 2026.
- [F2]This sale was to cover tax liabilities in the vesting of restricted stock.
- [F3]This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in equal monthly installments over four years, beginning on March 15, 2023.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001325710
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:07 PM ET
- Size
- 9.1 KB